Twist Bioscience Corp [TWST] stock prices are up 1.16% to $31.32 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TWST shares have gain 4.19% over the last week, with a monthly amount glided 3.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on November 04, 2025, when Stephens initiated its Overweight rating and assigned the stock a price target of $41. Previously, Wolfe Research started tracking the stock with Outperform rating on December 13, 2024, and set its price target to $60. On June 04, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $53 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $45 on January 17, 2024. Berenberg initiated its recommendation with a Buy and recommended $27 as its price target on September 27, 2023. Scotiabank started tracking with a Sector Outperform rating for this stock on January 05, 2023, and assigned it a price target of $33. In a note dated January 03, 2023, Evercore ISI upgraded an Outperform rating on this stock and boosted its target price from $28 to $36.
The stock price of Twist Bioscience Corp [TWST] has been fluctuating between $24.07 and $55.33 over the past year. Currently, Wall Street analysts expect the stock to reach $42.33 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $31.32 at the most recent close of the market. An investor can expect a potential return of 35.15% based on the average TWST price forecast.
Analyzing the TWST fundamentals
The Twist Bioscience Corp [NASDAQ:TWST] reported sales of 362.27M for trailing twelve months, representing a surge of 17.91%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -0.39%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.18 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.54 points at the first support level, and at 29.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.99, and for the 2nd resistance point, it is at 32.67.
Ratios To Look Out For
It’s worth pointing out that Twist Bioscience Corp [NASDAQ:TWST]’s Current Ratio is 3.90. On the other hand, the Quick Ratio is 3.60, and the Cash Ratio is 2.31. Considering the valuation of this stock, the price to sales ratio is 5.22, the price to book ratio is 3.94.
Transactions by insiders
Recent insider trading involved Cho Dennis, that happened on Nov 03 ’25 when 1019.0 shares were sold. President and COO, Finn Patrick John completed a deal on Nov 03 ’25 to sell 2755.0 shares. Meanwhile, SVP of Human Resources Green Paula sold 1084.0 shares on Nov 03 ’25.
